Organon Follistim AQ Clears FDA; Formulation Has Dosing Advantage, Firm Says

The ready-to-inject infertility treatment delivers 18% more follitropin beta than a conventional syringe, Organon says. The company also hopes to launch its implantable contraceptive Implanon this year.